Artificial Intelligence for Omics Data Integration

Omics technologies generate large and complex datasets, including genomics, transcriptomics, proteomics, and metabolomics. Each data type captures a different biological layer, but analyzing them separately limits clinical insight. 
Artificial Intelligence (AI) provides computational methods capable of integrating multi-omics and clinical data to support prediction, stratification, and treatment decision-making in personalized medicine.

                                                                                       

Why Omics Data Integration Is Challenging
Omics datasets are characterized by:
  • High dimensionality (thousands to millions of variables)
  • Heterogeneous data formats and scales
  • Biological noise and missing values
  • Complex, non-linear relationships between molecular features and clinical outcomes
 Traditional statistical approaches struggle to manage this complexity. AI methods are better suited to extract patterns across multiple molecular layers simultaneously

 Prospective directions in multi-omics research for myocardial infarction. 

Role of Artificial Intelligence
AI techniques, including machine learning and deep learning, are used to:
  • Combine genomic variants, gene expression, protein abundance, and clinical parameters
  • Identify relevant molecular features linked to disease mechanisms
  • Model interactions between biological pathways
  • Predict patient-specific treatment response or disease progression
 These models learn directly from data without requiring predefined biological assumptions, enabling discovery of previously unknown associations.

From omics technology to precision medicine in ALS. Multi-omics (e.g., genomics, transcriptomics, proteomics, epigenomics, metabolomics) data analysis and integration may allow patient stratification and targeted therapies. Through a “systems biology” approach, these technologies may move medicine from a “one-size-fits-all” toward a “personalized” model.

Clinical Applications
AI-driven omics integration is applied in:
  • Treatment response prediction, especially in oncology
  • Patient stratification for targeted therapies
  • Biomarker discovery across heterogeneous populations
  • Risk prediction for disease onset or relapse
 By integrating molecular and clinical data, AI models support more precise and personalized clinical decisions.

multi-omics have also application in drug target discovery and aging research

Data Quality and Interpretability Challenges
The reliability of AI predictions depends on
  • Data quality and standardization
  • Reproducibility of omics measurements
  • Transparent and interpretable models
 Black-box predictions without biological explanation can limit clinical trust. Current research focuses on explainable AI to improve clinical acceptance.

Competing Interest Statement

Integration into Healthcare Systems
For real-world use, AI models must be:
  • Integrated into clinical workflows
  • Compatible with electronic health records
  • Validated using real-world clinical data
  • Continuously updated as new evidence becomes available
 Without proper integration, AI tools risk remaining confined to research environments

A workflow for data integration for AI/ML modeling in precision medicine. ① A wide variety of data sources with diverse features exists. Hence, different approaches to data collection and pre-processing are needed ②. ③ Integrating such diverse and heterogeneous data is one of the grand challenges to the successful application of AI/ML approaches to Precision Medicine. Overcoming such challenges will bring important improvements to Precision Medicine

Conclusion
Artificial Intelligence plays a central role in integrating omics and clinical data for personalized medicine. By capturing complex molecular interactions, AI enables prediction of treatment response and supports targeted therapeutic strategies. However, clinical impact depends on data quality, model transparency, and effective integration into healthcare systems.


Contact us

CRISPR‑Based Gene Editing in Personalized Medicine: Precision at the DNA Level